Category Medicine and Healthcare
Press Release
CASI Pharmaceuticals Announces Safety Monitoring Committee Recommendation to Escalate CID-103 Dose to Next Cohort in Phase 1 Immune Thrombocytopenia (ITP) Study
- CID-103 is a potential best-in-class, clinical stage anti-CD38 monoclonal antibody - Safety profile observed in first four dose cohorts supports continued development - No serious adverse events or dose-limiting toxicities have been reported Read More
Press Release
Remedium Bio Announces Strategic Collaboration With Lilly to Develop Gene Therapies for Obesity and Type 2 Diabetes
· Research focused on long-acting therapeutics based on Remedium's proprietary Prometheus™ platform · Multiple targets for the treatment of Obesity and Type 2 Diabetes Read More
Press Release
DEA National Marijuana Embarrassment: DEA Forces VA to Import Cannabis After Blocking MMJ BioPharma Cultivation US Supply
Is the DEA the Epitome of Ineptitude? "Why is the VA importing cannabis that U.S. companies have been ready to produce for years? If American cannabis is ‘too dangerous' for research, why is foreign cannabis treatment suddenly acceptable for our veterans?" asked Duane Boise, CEO of MMJ International Holdings. Read More
Press Release
Trump's DEA Must Choose: Reward Illegal Marijuana Operators or Sanction Science?
As the Trump administration cracks down on foreign drug cartels, MMJ BioPharma Cultivation exposes a hypocritical domestic policy: rewarding illegal state marijuana operators with massive tax breaks while blocking federally compliant medical research for seven years. The question for DEA Administrator Cole is simple? Read More
Press Release
Pace Life Sciences to Hold Free Virtual Webinar Through Outsourced Pharma on USP Guidelines for Extractable and Leachable Manufacturing Risk Assessment
Pace® expert to leverage extensive knowledge to provide guidance on risk assessments for pharmaceutical and biopharmaceutical companies Read More
Press Release
Finetech Launches New Technology for NJP-1200 Capsule Filling Equipment, Achieve Soft Capsule+Granule Into One Hard Capsule
Finetech, a top manufacturer of pharmaceutical machinery, announces its new technology for the NJP 1200 capsule filling machine. This machine can fuse soft capsule + granule into one hard capsule. Read More
Press Release
Interactive Strength Inc. (Nasdaq:TRNR) Investment Drives Sportstech's Accelerating Growth, with 45% Revenue Growth in August
Current FX rates indicate that the LTM August 2025 Revenue would be approximately $58M with $6M in EBITDA Sportstech announced May to August 2025 revenue growth of 20% YOY TRNR Investment in Sportstech working capital is accelerating growth for the pending acquisition, with full-year 2025 Revenue growth expected to exceed 30% Strong Business Momentum and Profitable Growth Reinforces Underscore Target's Operational Strength and Logic of Acquisition in advance of Closing Read More
Press Release
Aptevo Unveils Two Next-Generation, Industry Leading Trispecifics, Expanding CD3 Oncology Pipeline to Five Molecules
New candidates, APVO452 and APVO451, harness proprietary ADAPTIR-FLEXTM design to target prostate and multiple solid tumor cancers by simultaneously engaging tumor antigens, T cells, and immunosuppressive cells Mipletamig-driven clinical validation of the CRIS-7-derived CD3 binding domain underpins Aptevo's introduction of new, trispecific CD3-directed anti-cancer molecules Read More
Press Release
MygoGenesis Releases White Paper Detailing aLAL(TM) - a Sustainable, Lab-Grown Amebocyte Lysate Designed for Reliable Endotoxin Testing
New Data Describe Lab-Grown Amebocytes (aLAL™) That Aim to Match Native LAL Performance While Solving Supply, Cost and Sustainability Constraints Read More
Press Release
Military Veterans Join Virtue Recovery to Expand Community Outreach With Hope and Support
Virtue Recovery has expanded its Business Development Team with the addition of two American Veterans, Adam Khosroabadi and Chauncy Nash. Both bring extensive military service, professional expertise, and a passion for helping others, strengthening Virtue Recovery's mission to provide compassionate, whole-person treatment across its nationally accredited centers. Read More
Press Release
DEA Marijuana Decision Showtime: MMJ Issues Demand Letter on DEA
Duane Boise stated "In a September 3rd letter to DEA Terry Cole, that the Administrative Procedure Act requires agencies to act "within a reasonable time." If no decision is issued soon, MMJ will pursue all available remedies in federal appeals court to the supreme court if necessary". Read More
Press Release